Andrew J. Warmus

Andrew advises buyers and sellers in acquisitions, divestitures, and strategic transactions often involving complex, multijurisdictional carve-out transactions in regulated industries. He also provides counsel to several portfolio companies on a wide range of matters and builds and leads bespoke teams to deliver commercial solutions.

Andrew is a member of the Firm’s Cross-Border Steering Committee.

See less

• Represented Longshore Capital Partners in its strategic growth partnership with Prochant Healthcare
• Represented Select Equity Group L.P. in multiple platform company acquisitions and subsequent add-on transactions
• Represented Performant Capital in multiple platform company acquisitions and add-on transactions
• Represented Lindsay Goldberg in multiple transactions and governance matters for its Ultra Clean Express Car Wash and Dash Car Wash platform
• Represented Sojourner Consumer Partners in connection with multiple acquisitions and venture strategies
• Assisted Spaulding Ridge, a leading advisory and technology implementation firm, with its formation, multiple acquisitions, and in connection with its international expansion and further growth
• Represented Further Point Enterprises in the acquisition of Foxtrot assets and related corporate governance and equity investment matters
• Represented Kin Group Pty Ltd in multiple matters, including its investment in Remedy Drinks International Limited
• Represented Walgreens Co. in connection with the formation of AllianceRx Walgreens Prime, a strategic joint venture between Walgreens Co. and Prime Therapeutics to create one of the largest specialty and home delivery pharmacies in the United States*
• Represented Abbott Laboratories in its sale of the St. Jude Medical Angio-Seal and FemoSeal vascular closure devices business to Terumo Corporation*
• Represented Abbott Laboratories in the divestiture of Alere Inc.’s Triage® MeterPro cardiovascular and toxicology business and B-type Naturietic Peptide assay business run on Beckman Coulter analyzers*
• Represented Abbott Laboratories in connection with the sale of its non-US developed markets branded generics pharmaceuticals business to Mylan N.V. in exchange for an approximately 21% equity interest in Mylan*
• Represented Safran S.A. in connection with its strategic joint venture with The Boeing Company*
• Represented ARIAD Pharmaceuticals, Inc. in the divestiture of its European operations to Incyte Corporation*
• Represented Fortune Brands Innovations, Inc. in connection with multiple early-stage investments and commercial arrangements with startup companies*
• Represented CommScope Holding Company, Inc. in its acquisition of TE Connectivity’s telecom, enterprise, and wireless business*
• Represented F45 Training, Inc. in connection with the equity investment by an investor group led by Mark Wahlberg*
• Represented MiddleGround Capital in its acquisition of Shiloh Industries, Inc. and multiple related transactions*

*Matter handled prior to joining McDermott.

See less